The strongest upregulation was for NPTX2 mRNA, which was consistently increased twofold in TDP-43-negative neurons from patients with FTLD–ALS compared with controls (Fig. 4a). The gene discussed is NPTX2; the disease is amyotrophic lateral sclerosis.